Corcept Therapeutics Ratios (2010-2026) | CORT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	98.49%	98.67%	98.63%	98.67%	98.73%	98.68%	98.56%	98.69%	98.66%	98.67%	98.61%	98.27%	98.46%	98.43%	98.37%	98.47%	98.23%	97.79%	98.74%	98.25%
EBT Margin (Quarter)	35.00%	37.77%	37.17%	28.66%	31.01%	32.44%	23.56%	17.45%	27.97%	29.44%	27.18%	23.84%	25.40%	29.00%	17.57%	6.12%	16.30%	7.34%	4.90%	-27.12%
EBIT Margin (Quarter)	34.88%	37.69%	37.10%	28.57%	30.40%	31.39%	21.83%	14.06%	25.13%	25.22%	23.39%	20.09%	21.73%	25.53%	13.89%	2.17%	13.72%	4.92%	2.22%	-30.08%
EBITDA Margin (Quarter)	28.92%	31.59%	32.09%	23.13%	30.40%	31.39%	21.83%	14.06%	25.13%	25.22%	23.39%	20.09%	21.73%	25.53%	13.89%	2.17%	13.72%	4.92%	2.22%	-30.08%
Operating Margin (Quarter)	34.88%	37.69%	37.10%	28.57%	30.40%	31.39%	21.83%	14.06%	25.13%	25.22%	23.39%	20.09%	21.73%	25.53%	13.89%	2.17%	13.72%	4.92%	2.22%	-30.08%
Net Margin (Quarter)	28.96%	31.70%	32.44%	24.33%	26.50%	33.96%	16.04%	14.96%	23.24%	25.22%	23.00%	18.74%	21.44%	25.58%	16.71%	12.90%	17.80%	9.32%	11.83%	-18.92%
FCF Margin (Quarter)	48.28%	50.50%	49.95%	37.61%	17.43%	32.73%	32.37%	24.57%	35.84%	42.78%	4.08%	16.18%	24.89%	39.25%	32.95%	2.97%	22.75%	26.24%	19.00%	-10.29%
Efficiency
Inventory Average (Quarter)	4.81M	4.83M	4.99M	5.03M	5.26M	5.74M	6.07M	6.25M	6.66M	7.21M	7.62M	7.46M	7.77M	8.20M	10.23M	13.39M	13.32M	12.31M	12.61M	12.88M
Assets Average (Quarter)	560.44M	576.94M	504.58M	445.94M	482.24M	514.81M	558.34M	600.64M	571.24M	559.32M	607.77M	638.73M	685.25M	749.41M	812.40M	843.50M	824.09M	812.66M	830.13M	825.77M
Equity Average (Quarter)	516.74M	531.45M	458.02M	391.81M	425.07M	457.85M	487.60M	515.71M	475.60M	441.65M	484.19M	527.28M	572.05M	617.54M	659.21M	681.44M	659.54M	633.85M	639.85M	642.90M
Invested Capital (Quarter)	522.67M	540.23M	375.81M	407.81M	442.33M	473.36M	501.84M	529.58M	421.61M	461.68M	506.70M	547.86M	596.24M	638.84M	679.59M	683.28M	635.79M	631.90M	647.80M	637.99M
Asset Utilization Ratio (Quarter)	0.61	0.61	0.73	0.85	0.81	0.77	0.72	0.69	0.75	0.80	0.79	0.82	0.83	0.84	0.83	0.81	0.87	0.91	0.92	0.93
Leverage & Solvency
Interest Coverage Ratio (Quarter)
Debt to Equity (Quarter)
Debt Ratio (Quarter)
Equity Ratio (Quarter)	0.92	0.92	0.89	0.87	0.89	0.89	0.86	0.86	0.80	0.78	0.82	0.84	0.83	0.81	0.81	0.81	0.79	0.77	0.77	0.78
Times Interest Earned (Quarter)
Valuation
Enterprise Value (Quarter)	-369.98M	-361.33M	-223.53M	-345.53M	-370.09M	-396.26M	-431.67M	-465.06M	-363.26M	-355.23M	-368.22M	-410.76M	-473.16M	-380.34M	-383.33M	-322.76M	-342.23M	-421.68M	-372.15M	-338.18M
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	20.74%	22.23%	27.24%	33.86%	30.26%	27.46%	23.18%	19.30%	20.68%	22.43%	21.32%	22.52%	21.89%	23.00%	20.39%	15.83%	15.01%	10.24%	6.75%	-1.21%
Return on Invested Capital (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Corcept Therapeutics Ratios (2010-2026) | CORT

Create an account

Sign In

Reset Password